Concepedia

I. Laszlovszky

IL

Statistics

Publications

48

Citations

3.8K

H-Index

34

Active since

1990

Affiliations

Gedeon Richter (Hungary)(Current)

Allergan (United States)

Prescott College

Innsbruck Medical University

Meridien Research

I. Laszlovszky is an author at Gedeon Richter (Hungary) specializing in psychopharmacology, neuropharmacology, and antipsychotic pharmacotherapy.

ORCID

Publications per year

1990–2022

48

Publications

48

Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist–Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile

Béla Kiss, Attila Horváth, Zsolt Némethy et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 365 citations

, , +16

Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial

György Németh, I. Laszlovszky, Pál Czobor et al. · The Lancet · 2017 · 352 citations

, , +14

An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression

Suresh Durgam, Willie Earley, Alan Lipschitz et al. · American Journal of Psychiatry · 2015 · 206 citations · Full text

, , +17

An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial

Suresh Durgam, Anju Starace, Dayong Li et al. · Schizophrenia Research · 2014 · 192 citations · Full text

, , +17

Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia

John M. Kane, Stephen R. Zukin, Yao Wang et al. · Journal of Clinical Psychopharmacology · 2015 · 179 citations

, , +17

1–5 of 48